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Abstract
Chronic inflammation affects most stages of tumorigenesis, including initiation, promotion, malignant differentiation,
invasion and metastasis. Inflammasomes have been described as involved with persistent inflammation and are known to
exert both pro and antitumour effects. We evaluated the influence of apoptosis-associated speck-like protein containing a
caspase recruitment domain (ASC) and caspase (CASP)-1 in the antitumor immune response using a multistage model of
squamous cell carcinoma (SCC) development. Absence of ASC and CASP-1 resulted in an earlier incidence and increased
number of papilloma. Loss of inflammassome function in mice resulted in decreased presence of natural killer (NK), dendritic
(DC), CD4+, CD8+ and CD45RB+ T cells in the tumor lesions as well as in lymph nodes (LN) compared with WT mice. Increased
percentage of CD4+CD25+Foxp3+ T cells was associated with association with inflammasome loss of function. Moreover,
significant differences were also found with neutrophils and macrophage infiltrating the lesions. Myeloperoxidase (MPO),
but not elastase (ELA), activity oscillated among the groups during the SCC development. Levels of proinflammatory
cytokines IL-1b, IL-18, Tumor Necrosis Factor (TNF)-a and Interferon (IFN)-c were decreased in the tumor microenvironment
in the absence of inflammasome proteins. These observations suggest a link between inflammasome function and SCC
tumorigenesis, indicating an important role for inflammasome activation in the control of SCC development.
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Introduction
An effective immune response is important to restrict the
development of the disease, mainly via induction, function, and
regulation of effector lymphocytes [1,2]. Cancer immunosurveil-
lance is described as lymphocytes acting as sentinels in recognizing
and eliminating continuously arising transformed cells, and it is
exerted mostly by cytotoxic CD8+ T-lymphocytes (CTL) while
specific immune suppression is associated with tumor malignancy
and progression [2–4]. CD4+ T cells either contribute to tumor
destruction or facilitate tumorigenesis depending on their pheno-
type and function [5]. Among the different subpopulations, Type 1
CD4+ T cells (Th1) facilitate tumor rejection by assisting in the
CTL response. On the other hand, several studies have shown that
CD4+ T regulatory cells (Tregs) promote tumor progression by
inhibiting the functions of CD8+ T cells and natural killer (NK)
cells and that the accumulation of Treg cells is associated with a
poor prognosis [5–7]. In spite of crucial role of T cells in cancer
immunosurveillance, the innate immunity also plays an important
part in the development and control of tumor response [8,9].
Neutrophil Elastase (ELA) and Myeloperoxidase (MPO) have also
been directly or indirectly related to the cancer immunoediting
and metastasis [8,9]. In recent years, a molecular platform
assembled in the host cytosol, named inflammasome, has been
described. The proteolytic maturation of inflammatory cytokines
IL-18 and IL-1b may result from inflammasome activation [10].
Inflammasomes are a set of intracellular protein complexes that
enable autocatalytic activation of inflammatory caspases, as
caspase-1, which drive host immune responses by releasing pro-
inflammatory cytokines and inducing pyroptosis [11]. Their
activation occurs in response to pathogens (PAMPs) and stress or
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danger signals (DAMPs) promoting the maturation of cytokines of
the IL-1 family: IL-1b and IL-18 [12,13]. Different studies have
been showing the important role of IL-18 as the primary IFN-c
inducing cytokine and responsible to promote a Th1 response
[14,15].
Besides promotion of a Th1 response, IL-18 has been described,
as along with IL-12 and other cytokines, as being important for
NK cells action upon aberrant cells [16,17]. Thus, we rationalize if
the tumor cells do not elicit the inflammasome mediated innate
immune response they would be regarded as self and therefore will
escape of the T cell immune surveillance and immunogenic cell
death (ICD) [18,19]. ICD markers are released from apoptotic and
necrotic cells (e.g. cancer cells) to stimulate the innate and adaptive
immune responses. Cell death products such as damage-associated
molecular pattern molecules (DAMPs) play an essential role in
addressing that process [18,19]. Interaction of these DAMPs with
various receptors on the surface of immune cells, as well as stromal
cells, is required to evoke the ICD-induced anti-tumor immune
responses [18].
IL-1b is a potent pro-inflammatory cytokine, whose levels are
increased in the cancer conditions [10,12]. The transcription of
pro-IL-1b is induced by the activation of the transcription factor
nuclear factor-kB (NF-kB), whereas pro-IL-18 is constitutively
expressed and its expression is increased after cellular activation
[11,13]. Therefore, both pro-inflammatory cytokines are con-
trolled by two checkpoints: the transcription, and maturation and
release [13]. In turn, the activation of IL-1b by CASP-1 leads to
the recruitment and the activation of immune cells at the site of
tissue damage [13]. Several NOD-like receptors (NLRs) act as
sensor molecules that can trigger the formation of inflammasomes.
Most of the inflammasomes that have been described to date
contain NLRs: NLRP1 (NOD-, LRR- and pyrin domain-
containing 1), NLRP3, NLRP6, NLRP7, NLRP12 and NLRC4
(13, 20-23). AIM2 and the NLRP proteins, with the exception of
NLRP1, require an adaptor protein - Apoptosis-associated speck-
like protein containing a caspase recruitment domain (ASC)- to
activate CASP-1 [13,20–25]. The influence of inflammasome in
the carcinoma development has been shown to have contrasting
roles in the interplay between malignant cells and the tumor
microenvironment [5,10,24–26]. Studies have shown different role
of ASC according to the type of tumor [26,27]. Because the
inhibition of inflammasomes has been shown to have profound
effects on carcinogenesis and tumor progression [10], we decided
to investigate the inflammasome function in the development of
experimentally induced murine squamous cell carcinoma (SCC).
Materials and Methods
Mice
Experimental animals were cared for in accordance with of the
National Council of Health and the University of Sa˜o Paulo
(Bauru, Sa˜o Paulo, Brazil) committee guidelines. C57BL/6 mice
[Wild-type (WT)], ASC (ASC-KO), and CASP-1-deficient (CASP-
1-KO) mice (6–8 weeks old) were obtained from Ribeira˜o Preto
Medical School, University of Sa˜o Paulo. Each mouse was housed
in an isolated cage, and food and water were provided ad libitum.
All experimental procedures involving animals in this study were
reviewed and approved by the Animal Research Ethics Commit-
tee of the Bauru School of Dentistry, University of Sa˜o Paulo.
DMBA/PMA-induced skin carcinogenesis initiation-
promotion experiments
Eight-week-old female mice were topically treated with four
doses of 7,12-dimethylbenz[a]-anthracene (DMBA) (25 mg in
200 ml of acetone) and biweekly doses of phorbol 12-myristate
13-acetate (PMA) (200 ml of a 1024 M solution in acetone) for 20
weeks. Both DMBA and PMA (Sigma–Aldrich) solutions were
applied using a pippete (200 ml) in acetone onto the shaved back
skin Papilloma incidence was monitored every two days.
Papillomas were characterized by folded epidermal hyperplasia
protruding from the skin surface, and carcinomas were charac-
terized as endophytic tumors presenting as plaques with an
ulcerated surface. Samples were collected at different time-points
after initiation and were processed as described below.
Histological analysis
Tissue samples were collected from tumour sites and fixed with
10% (vol/vol) formalin for 6 hours at room temperature. The
tissues were subsequently dehydrated in ethyl alcohol followed by
washes in xylol and were then embedded in paraffin. Each sample
was sectioned into 5- to 7-mm-thick slices that were dried onto
slides and stained with hematoxylin and eosin.
Isolation of leukocytes
To characterize the leukocytes in the tumor site, biopsies of skin
lesions from mice were collected and incubated for 1 h at 37uC in
RPMI 1640 medium containing 50 mg/ml of a collagenase CI
enzyme blend (Boehringer Ingelheim Chemicals). The tissues were
subsequently dissociated for 4 min in RPMI 1640 with 10% serum
and 0.05% DNase (Sigma-Aldrich) using a Medmachine (BD
Biosciences) according to the manufacturer’s instructions. The
tissue homogenates were filtered using a 30-mm cell strainer
(Falcon; BD Biosciences). Leukocyte viability was evaluated by
Trypan blue exclusion, and these cells were subsequently used for
cell activation and immunolabeling assays. Isolated cells were
counted using Newbauer chamber. The total number of cells was
normalized against the events acquired in flow cytometry.
Antibodies and flow cytometry analysis
For immunostaining, APC-, PerCP-, PE- and FITC conjugated
Abs against CD3, CD4, CD8, CD11c, CD19, CD25, CD28,
CD45RA, CD45RB, CD62L, NK1.1, F4/80, GR-1 and the
respective isotype controls were used (BD Biosciences). PE-
CD209/DC SIGN was acquired from EBiosciences. The intra-
cellular detection of Foxp3 in leukocytes was performed using
Cytofix/Cytoperm and Perm/Wash buffer from BD Biosciences
according to the manufacturer’s instructions. Briefly, the cells were
labeled with Abs to the cell surface, such as FITC anti-CD25 and
PerCP-conjugated anti-CD4. Following the staining of surface
markers, the cells were fixed, permeabilized and stained with PE-
labeled anti-mouse Foxp3 (MACS Miltenyl Biotech), The samples
were acquired on a FACSort flow cytometer, and the data were
analyzed using CellQuest software (BD Biosciences).
MPO and ELA activity quantification
MPO and ELA activities were measured in the supernatants
from lesions. Lesion sample supernatants were obtained by
disaggregating the tissue through treatment with RPMI 1640
medium containing 0.25% collagenase (Worthington) and were
frozen at -80uC until analysis. The total protein concentration was
measured using a Quick Start Bradford Protein assay kit (Bio-Rad,
CA, USA). MPO activity in the supernatants was assayed by
measuring the change in absorbance at 450 nm using 3,39,5,59
tetramethylbenzidine (50%) and H2O2 (50%) (Opteia Set B; BD
Biosciences, San Diego, CA, USA). The reaction was stopped after
15 min using phosphoric acid (1M).
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For the ELA analysis, supernatants were individually incubated
with insoluble elastin-Congo Red dye (E0502-5G; Sigma- Aldrich)
diluted in 100 mM Tris–HCl buffer (pH 8.8) containing 0.01%
sodium azide (Sigma- Aldrich) in a 96-well plate. The optical
absorption of the hydrolysis product was read with a Microplate
Reader (Bio-Rad Model 680; Bio-Rad Laboratories, Hercules,
CA, USA) at 450 nm after 24 h incubation at 37uC. ELA activity
was calculated from a standard curve of elastase from human
leucocytes (Sigma-Aldrich) and expressed in units/ml.
Cytokine assays
IL-1b, IL-10, IFN-c and TNF-a levels in the supernatants of
samples were individually quantified using ELISA kits, according
to the manufacturer’s instructions (BD Pharmingen Corp., San
Diego, CA). IL-18 was quantified through Mouse IL-18 Platinum
ELISA (Ebiosciences) kit according to the manufacturer’s instruc-
tions.
Statistical analysis
The results are expressed as the mean 6 SD, and statistical
analysis was performed using two-way ANOVA followed by
Bonferroni’s test (GraphPad software 4). p#0.05 was considered to
indicate statistical significance.
Results
Inflammasome loss of function accelerated the
appearance of the SCC in mice
To investigate the effects of inflammasome signaling on tumor
initiation and development, we used a modified well-established
protocol to induced skin tumorigenesis on WT, ASC-KO and
CASP-1-KO mice [26]. Inflammasome loss of function signifi-
cantly enhanced papilloma incidence, rate and size, when
compared with WT mice (Fig. 1A). Macroscopically visible
papillomas were detected at the 5th week of TPA application on
CASP-1-KO, at the 7th week on ASC-KO, and only at the 10th
week on WT mice (Fig. 1A). In WT group, all mice developed
papilloma by the 20th week of DMBA/TPA application (Fig. 1A).
In contrast, loss of inflammasome function enhanced the process
of papilloma development. All ASC-KO mice developed visible
papilloma by the 10th week after carcinogenic induction (Fig. 1A)
while all CASP-1-KO mice developed papilloma by the 18th week
(Fig. 1A). The average tumor volume per mouse in the CASP-1-
KO mice was significantly higher compared with the WT group
(Fig. 1A). No significant differences were found relating tumor
volume between ASC-KO and WT mice (Fig. 1A). Moreover,
CASP-1-KO group exhibited significantly more lesions than the
WT group from 7th week until 20th week while ASC-KO showed
lesions from the 9th week until the 19th week (Fig. 1A). The
proportion of mice presenting papilloma and/or tumor is shown in
the Table 1.
By the 12th week, histological analysis of lesion samples from
theinflammasome-deficient groups demonstrated typical papillo-
ma characteristics (Fig.1B). There was discrete inflammation
around the skin appendages which were less numerous than in the
control tissue. Each finger like projection was lined by stratified
squamous epithelium and contained a thin central connective
tissue. The histological analysis also demonstrated that the groups
with inflammasome loss of function presented moderated inflam-
matory infiltrate and some mitotic cells (Fig. 1B) that remained at
the 16th week (Fig. 1B). We identified epithelial hyperplasia,
localized regions with hyperkeratosis, presence of atypical mitotic
cells exhibiting dense chromatin and epithelial islets (Fig. 1B). At
the 20th week, hyperkeratosis, epithelial hyperplasia, epithelial
crest, islets and invasive cords of malignant squamous epithelial
cells arose independently from epithelium surface inside the
connective tissue in KO mice (Fig. 1B). There was also an
increased inflammatory infiltrate, atypical mitosis areas, poor
differentiated pattern and presence of pseudoglandular append-
ages (Fig. 1B). The histological analysis of skin samples from WT
mice, at the 12th week, showed desmosomes on outer surface of the
epithelium, presence of inflammatory cells in the stratum
spinosum and normal keratinocytes in stratum corneum (Fig. 1B).
At the 16th week, less keratin alteration, moderate inflammatory
infiltrate, presence of mitotic cells, and a lack of epithelial islet
formation was also observed (Fig. 1B). At the 20th week, a
pronounced presence of inflammatory cells, epithelial islets,
mitosis and moderate dysplasia were observed in WT samples
(Fig. 1B). Altogether, these results demonstrate that inflammasome
activation during tumorigenesis can attenuate tumor progression.
Inflammasome activation regulates the inflammatory
infiltrate of SCC redirecting it to a tumor suppressor
phenotype
In order to verify whether inflammasome signaling alter
immune cells infiltration during SCC development, the population
of leukocytes present in lesions was analyzed (Fig. 2). At the 12th
week, inflammasome loss of function decreased leukocytes
infiltration into the tumor microenvironment [ASC-KO
(2.160.76106) and CASP-1-KO (1.460.36106)], as compared
to WT mice (2.7560.166106) (Fig. 2A). At the 20th week, we
found no statistically significant differences in the leukocyte
infiltration among the ASC-KO and CASP-1-KOgroups
(Fig. 3A). Using FSC and SSC analysis we determined the
phenotype of infiltrating cells. Phenotypic analysis of leukocyte
population demonstrated significantly decreased T lymphocytes
(CD4+ and CD8+ T cells), DC, NK cells, neutrophils and
macrophages infiltration in lesions from ASC-KO and CASP-1-
KO mice when compared with the WT group (Fig. 2A). With
respect to B cell infiltration, we found no statistically significant
differences between the ASC-KO, CASP-1-KO and WT groups
(Fig. 2A). At the 20th week, we observed differences in the type of
leukocyte infiltrating the lesions (Fig. 3A). Lesions from both ASC-
KO and CASP-1-KO exhibited diminished DC infiltration as
compared with WT; CASP-1-KO, but not ASC-KO mice,
showed significantly decreased CD3+CD4+, as well as CD3+CD8+
T cells when compared with WT mice (Fig. 3A). NK1.1+ cells
were also decreased in the lesions from both ASC-KO and CASP-
1-KO groups as compared with WT mice (Fig. 3A). However, we
did not observe differences in the B cells, neutrophils and
macrophages in the lesions of all groups at the 20th week (Fig. 3A).
Altogether, data demonstrate that the loss of inflammasome
function influenced on leukocytes infiltration into the tumor
microenvironment.
Since CD4+CD25+ T cells expressing Foxp3 (regulatory T cells)
have been related to the progression of SCC [6,7], the presence of
these cells in the tumor was evaluated. At the 12th week, significant
increase was found in the CD4+CD25+Foxp3+ T cells infiltrating
lesions in the ASC-KO (29.9613%) and CASP-1-KO (9.765%)
as compared with WT mice (2.561%) (Fig. 2B). Similar results
were found at the 20th week (Fig. 3B). Different studies indicate
that CD8+ T lymphocytes can also exhibit suppressor activity by
inhibiting Th1 proliferation [28–30]. For this reason, the presence
of these cells in the tumor microenvironment was also investigated.
The infiltration of suppressor CD8+CD282CD62L2 T cells (Ts)
was significantly increased in ASC-KO as compared to WT mice
(Fig. 2B). Different from that seen at the 12th week,
CD8+CD282CD62L2 T cells numbers were increased only in
Squamous Cell Carcinoma and Inflammasome
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CASP-1-KO lesions at the 20th week (Fig. 3B). Altogether, these
data indicate a redirection of immune tumor response in the
absence of inflammasome signaling, culminating in tumor
suppressor immunity.
In order to determine whether or not the lymphocytes
infiltrating SCC lesions presented a memory phenotype, we
analyzed percentages of T cells expressing CD45RA and CD45RB
[31–32]. CD4+CD45RB+ T cells were detected in lower frequency
from tumors samples of mice with inflammasome loss of function
Figure 1. Absence of inflammasome molecules induced an increase of papilloma incidence and volume during SCC development.
ASC-KO (gray square), CASP-1-KO (black square) and WT (white square) mice were treated according to a chemical carcinogenic protocol using DMBA
and PMA for 20 weeks. (A) The incidence, average number and volume of papillomas were determined. Data shown represent mean6 SEM; *p#0.05,
** p#0.01, *** p#0.001 compared with WT mice. Representative data are show from at least three independent experiments. (B) Representative
haematoxylin and eosin staining of skin section from 12, 16 and 20 weeks after SCC induction. Scale bars represent 50 uM.
doi:10.1371/journal.pone.0107170.g001
Squamous Cell Carcinoma and Inflammasome
PLOS ONE | www.plosone.org 4 September 2014 | Volume 9 | Issue 9 | e107170
Table 1. Histologic analysis of tumors from wild type and inflammasome-deficient mice.
Tumor WT (%) ASC-KO (%) CASP-1-KO (%)
Papilloma 8/11 (73.3) 11/11 (100) 11/11 (100)
SCC 1/11 (9.1) 7/11 (63.6) 10/11 (90.9)
Wild type (WT), ASC and CASP-1 deficient mice were followed until 20 weeks after skin carcinogenesis, and results from histological analysis were tabulated and
compared.
doi:10.1371/journal.pone.0107170.t001
Figure 2. Characterization of SCC lesions in the absence of inflammasome after 12 weeks. (A) The absolute number and phenotype of
leukocytes in the tumor lesions were determined by flow cytometry. (B) Flow cytometry analyses of CD25+Foxp3+, CD45RA+, CD45RB+ and
CD282CD62L2 expression on CD4 e CD8 T cells. (C) Myeloperoxidase (MPO) and elastase (ELA) activity in tumor microenvironment. (D) Cytokines
profile in tumor microenvironment at 12 weeks after SCC induction. Values are mean 6 SEM; *p#0.05, *** p#0.001 compared with WT mice.
doi:10.1371/journal.pone.0107170.g002
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at 12th and 20th week (Fig. 2B and 3B). On the other hand, higher
frequencies of CD4+T cells expressing CD45RA were detected in
samples from CASP-1-KO mice at the 12th week as compared
with the WT mice (Fig. 2B). In relation to CD8+CD45RB+T cells,
they were detected in lower frequencies in the lesions from ASC-
KO mice at the 12th week and 20th week (Fig. 2B and 3B). While
we observed an increase of CD8+ T cells expressing CD45RB in
the lesions from WT at 20th week (Fig. 3B), the percentage of this
population still similar KO groups at the 12th and 20th week
(Fig. 2B and 3B). No significantly differences were detected in
frequencies of CD8+CD45RA+ T cells (Fig. 2Band 3B). These
Figure 3. Characterization of SCC lesions in the absence of inflammasome after 20 weeks. (A) The absolute number and phenotype of
leukocytes in the tumor lesions were determined by flow cytometry. (B) Flow cytometry analyses of CD25+Foxp3+, CD45RA+, CD45RB+ and
CD282CD62L2 expression on CD4 e CD8 T cells. (C) Myeloperoxidase (MPO) and elastase (ELA) activity in tumor microenvironment. (D) Cytokines
profile in tumor microenvironment at 20 weeks after SCC induction. Values are mean 6 SEM; *p#0.05, *** p#0.001 compared with WT mice.
doi:10.1371/journal.pone.0107170.g003
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data show that the absence of inflammasome function clearly
decreased the presence of memory T cells infiltrating SCC lesions.
In order to determine whether the tumor-associate neutrophils
(TAN) influenced the MPO and ELA activity, which are
mediators associated with SCC development [33], we analyzed
for the presence of these enzymes in the tumor microenvironment.
At 12 weeks, we detected higher activity of MPO in the lesions
from WT mice than KO groups and no differences related to ELA
were observed among the groups (Fig. 2C). However, we detected
similar activity of MPO and ELA in the lesions from all groups at
the 20th week (Fig. 3C).
Since the inflammasome cascade is known to control the
secretion of IL-1b and IL-18, and both cytokines may influence
the activation of immune cells and induce the secretion of Th1
cytokines, the levels of these cytokines were analyzed in the lesions
(Fig. 2D and 3D). We found diminished levels of IL-1b, IL-18 and
TNF-a levels in lesions from the KO mice when compared with
WT mice in both 12 and 20 weeks (Fig. 2D and 3D). The IFN-c
detection was lower only in lesions from CASP-1-KO (Fig. 2D)
while levels of IL-10 were similar among all groups at the 12th
week (Fig. 2D). At the 20th week, IFN-c levels were significantly
decreased in the lesions from KO mice as compared with WT
mice (Fig. 3D). However, levels of IL-10 were similar among all
groups at the 20th week (Fig. 3D). These data indicate that the
production of cytokines related to an antitumoral response is
dependent on inflammasome function.
Absence of inflammasome modifies the number of cells
in the draining lymph nodes
In order to understand if the inflammasome-dependent immune
response changes occur only in the tumor microenvironment, the
population of leukocytes in the draining lymph nodes (LN) was
assessed (Fig. 4). Our data showed that loss of inflammasome
function lead to a decreased number of leukocytes in LN during
tumorigenesis (Fig. 4A). Lower numbers of NK, DC, CD4 and
CD8 T cells were detected in LN from mice with loss of
inflammasome function (Fig. 4B–E). CD8 T cells exhibited a
suppressor phenotype in the absence of inflammasome function
(Fig. 4D). The frequencies of CD4+CD45RB+ T cells were lower
in the LN from KO mice (Fig. 4E). CD4+CD25+Foxp3+ T cells
were increasing with tumor development; however, values found
in the LN from KO groups were significantly higher as compared
with WT mice (Fig. 4E). Altogether, data demonstrate that
inflammasome activation can influence in the LN immune
response development in the SCC progression.
Discussion
Data obtained from this study shows the effect of adaptor
proteins ASC and the enzyme CASP-1 in the protection against
SCC tumorigenesis and progression. Such inflammasome depen-
dence was probably associated with the development of a
suppressed immune response impairing the influx of T and NK
cells into the lesions as well as an antitumor response in the lymph
nodes. In the absence of inflammasome function, SCC lesions’
appearance occurred earlier, and the lesions were significantly
more abundant. NK cells are potent cytolytic/cytotoxic and
cytokine-producing effector cells in response to tumor targets, that
is important to modulate the adaptive immune response through
cytokines and DC cooperation [14,34,35]. NK cells are largely
known to have an important role in the tumour immunosurveil-
lance and destruction of aberrant cells [14,36]. The diminished
infiltration of these cells in the SCC lesions as well as in the lymph
nodes (data not shown) may be related to the more aggressive
disease in the loss of inflammasome function. However, ASC-KO
and CASP-1-KO groups had increased NK cells in the spleen at
5th month (data not shown). Therefore, we can speculate that the
loss of inflammasome signaling impairs the arrival of NK cells to
the tumor lesions, but not their generation. Perhaps, the activation
of NK cells in the loss of inflammasome function is impaired along
with their reduced infiltration in the lesions since IL-18, as well as
IL-1 b, has been shown to activate NK cells [37]. Besides, TNF-a
levels were reduced in the absence of inflammasome function. IL-
1b and IL-18 are cytokines promoted by inflammasome activation
and play an important role in modulating the adaptive immune
response, and also mediate T helper cells 1 (Th1)- cytokine
secretion [18,38]. In a separate experiment we noted that NK cells
from CASP-1-KO mice were less cytotoxic towards tumor cells
(data not shown). This date is in agreement with previous studies
showing enhancement of the cytolytic/cytotoxic activity of NK
cells is dependent upon cytokines of the IL-1 family [39]. We did
not find differences in the activation of NK cells from ASC-KO
mice (data not shown) and this result is in agreement with an
earlier report [40]. TNF-a and IFN-c levels also were decreased in
lesions from KO mice. In part, this could be explained by the fact
that IFN-c secretion is evoked by IL-18 in antigen- dependent as
well as independent pathways [41,42]. Therefore, decreased levels
of IL-18 produced with the absence of inflammasome function
might negatively influence IFN-c secretion. Although TNF-a had
been related to chronic inflammation and tumor promotion [43],
we have not seen ameliorated symptoms and immune response
against cancer from KO mice. Perhaps, TNF-a had a protector
role in this SCC model, since this cytokine also have been
described as involved with anti-tumor immune response in the
presence of IL-1b [43]. Both factors were elevated in the lesions
from WT mice compared with KO groups.
Anti-tumor immune responses must begin with the capture of
tumour-associated antigens by dendritic cells (DC), either deliv-
ered exogenously or captured from dead or dying tumour cells,
and migrate to draining lymph nodes [44]. Loss of inflammasome
function affected the phenotype of leukocytes infiltrating the
tumors (TILs). Herein, we report diminished DC in the lesions
from ASC-KO and CASP-1-KO mice. Since the presence of
tumor-infiltrating DC has been associated with a favorable
prognosis for the patient [44], our data suggest a poor prognosis
of the SCC associated with inflammasome loss of function. The
cardinal role of DCs in the development of the antitumor immune
response is their unique ability to engulf dying tumor cells, a
principal source of tumor-associated antigens (TAAs), and cross-
present TAAs to CD8+ T cells in the LNs [44]. We found
diminished DCs as well as CD4+ and CD8+ T cells in the LNs
from mice that had loss of inflammasome function. Therefore, the
signaling cascade mediated by the inflammasome activation seems
to be associated with DC activation and CD8+ T cell differenti-
ation. Our results have shown that CD4+ T cells were also
decreased in the lesions in the absence of inflammasome function.
These Th1 cells are necessary for priming tumor-specific CD8 T
cells, influencing the differentiation, expansion of tumor antigen-
specific CTLs, and generation/maintenance of long-term CD8+
memory T cell responses [45].
Upon antigen encounter, the DCs would also have to receive a
suitable activation signal, allowing them to differentiate extensively
to promote immunity as opposed to tolerance including enhanced
processing and presentation of tumor antigen-derived peptides
[46]. Antigen presentation by DCs at the steady state promotes
tolerance by Treg production, which would oppose an anti-tumor
response [46].Besides the presence of Tregs, increased expression
of CD45RA on lymphocytes, resulting in T-cell unresponsiveness,
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which facilitates immune evasion [6,7,12,46]. Our data also
showed increased CD4+ T cells expressing CD45RA in the lesions
from CASP-1-KO mice compared with WT group. Such
differences were not verified in the LN (data not shown), indicating
that these cells were increased only in the SCC lesions in the
absence of inflammasome components.
Reinforcing the suppression hypothesis, an increase of
CD4+CD25+Foxp3+ T cells was found in the SCC lesions and
LNs in both KO groups. A previous study related the suppressor T
cells and elevated production of IL-10 with the absence of ASC
[47]. Although we did not find an increase of IL-10 levels in the
absence of inflammasome, the presence of CD4+CD25+Foxp3+ T
cells has been currently associated with a poor prognosis in SCC
[6,7]. Although WT mice also exhibited Tregs in the lesions and
LN, proportions were decreased when compared with KO groups.
Therefore, the absence of inflammasome may possibly be
unbalancing the response against SCC to the suppressor
immunity.
CD8+CD282CD62L2 T cells are a group of cells that has been
shown to inhibit APC- mediated T cell activation by direct cell
contact-dependent mechanisms [28–30]. Although these cells were
present in all of the groups, KO mice exhibited increased levels of
CD8+CD282CD62L2 T cells in the lesions and LNs as compared
with WT group.
On the other hand, the presence of CD45RB+ T cells in lesions
and LN was increased with SCC progression in WT but not in
KO groups. The infiltration of CD45RO/RB+ T cells has been
largely associated with an improved prognosis in different types of
tumors [48,49]. Therefore, absence of inflammasome function
may also hamper with the development of CD4+CD45RB+ T cells
in the SCC lesions impairing an antitumoral response. Besides
their function against several types of tumor, CD45RB+ T cells
seem to be involved with the inflammasome-IL-1b production
[49] that might contribute to the lower levels of this cytokine in the
lesions and lymph nodes in the KO mice as compared with WT
group.
Although some inflammasomes (NLRC4 and NLRP1) can
activate CASP-1 through their CARDs without recruiting ASC;
the recruitment of ASC greatly enhances the complex formation
and the processing of IL-1b and IL-18 [19,20,23]. ASC has also
been described acting as a tumor-suppressor in keratinocytes [26].
Besides, it is largely known the role of IL-18 in the activation of
Th1 antitumoral immune response [11,46,50]. Therefore, other
factors found diminished in KO mice can collectively regulate the
recruitment of immune cells to the sites of tissue damage and
directly act in keratinocytes [51,52]. Altogether, these events
contribute to the susceptibility of these animals to a poor
prognostic of the disease in the loss of the inflammasome function.
Previous study found opposite results related to CASP-1KO mice
[26] but those differences may be resulted from the protocols
employed. Differences in the immune response of those mice could
not be completely established, allowing the control of the disease in
CASP-1KO mice due to low dose of DMBA used to initiate SCC
[26]. Although exacerbated inflammation is harmful to immune
response against SCC [33] and the absence of IL-1 could control
inflammation events [26] without disturbing the development of a
Figure 4. Characterization of leukocyte populations in the lymph nodes with SCC in the absence of inflammasome. The absolute
number of leukocytes (A), DC (B), NK (C) CD3+CD8+ (D), CD3+CD4+ (E) cells in the lymph nodes was determined by flow cytometry. The proportion of
and were determined in samples from ASC-KO (gray square), CASP-1-KO (black square) and WT (white square). Values are mean 6 SEM; *** p#0.001
compared with WT mice.
doi:10.1371/journal.pone.0107170.g004
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Th1 protector immune response. Also, costimulation of TLR2,
TLR4 (MyD88), and TLR7/8 enhances IL-1b secretion [53] and
all events have been correlated with SCC development [10,54,55].
However, we believe that the modulation of the immune response
in our investigation was the most responsible for exacerbating the
disease, and it is a consequence of an array of alterations from
inflammasome loss of function.
In conclusion, our data show that the inflammasome proteins
signalling are involved with the protection from chemical-induced
squamous cell carcinoma. Inflammatory responses play decisive
roles in different stages of tumor development, including initiation,
promotion, progression, invasion, and metastasis [33]. We verified
that the loss of inflammasome function ablated the development of
a protector response against SCC and negatively affected the anti-
tumor immune response. Herein we have shown that the
inflammasomes perform an important role in the regulation of
immune response in carcinogenesis through cell migration of
specific immune cell phenotypes, activation of these immune cells
and balancing the equilibrium of inflammatory and anti-inflam-
matory cytokines.
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